>https://nypost.com/2020/08/14/covid-19-vaccine-maker-curevac-shares-nearly-triple-in-nasdaq-debut/
notable
In June, the German government took a 23 percent stake in CureVac for about $343 million. In July, GlaxoSmithKline and the Qatar Investment Authority also bought a stake in the company.
Tuebingen-based CureVac secured a 75-million-euro loan from the European Investment Bank last month.
SAP SE co-founder Dietmar Hopp owns a controlling stake in CureVac and is expected to hold a little less than 50 percent after the listing, according to a company filing.
Bank of America, Jefferies, and Credit Suisse are lead underwriters for the IPO.